rs144176855
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong
The NM_001365999.1(SZT2):āc.2888A>Gā(p.Lys963Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000267 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K963E) has been classified as Likely benign.
Frequency
Consequence
NM_001365999.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SZT2 | NM_001365999.1 | c.2888A>G | p.Lys963Arg | missense_variant | 20/72 | ENST00000634258.3 | |
SZT2 | NM_015284.4 | c.2888A>G | p.Lys963Arg | missense_variant | 20/71 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SZT2 | ENST00000634258.3 | c.2888A>G | p.Lys963Arg | missense_variant | 20/72 | 5 | NM_001365999.1 | P1 | |
SZT2 | ENST00000562955.2 | c.2888A>G | p.Lys963Arg | missense_variant | 20/71 | 5 | |||
SZT2 | ENST00000470139.1 | c.1619A>G | p.Lys540Arg | missense_variant, NMD_transcript_variant | 11/18 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000362 AC: 91AN: 251482Hom.: 0 AF XY: 0.000316 AC XY: 43AN XY: 135918
GnomAD4 exome AF: 0.000273 AC: 399AN: 1461878Hom.: 0 Cov.: 33 AF XY: 0.000248 AC XY: 180AN XY: 727246
GnomAD4 genome AF: 0.000210 AC: 32AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74344
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2022 | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 963 of the SZT2 protein (p.Lys963Arg). This variant is present in population databases (rs144176855, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with SZT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 411928). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SZT2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 26, 2017 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 21, 2023 | Variant summary: C1orf84 c.2888A>G (p.Lys963Arg) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00034 in 282858 control chromosomes (gnomAD). To our knowledge, no occurrence of c.2888A>G in individuals affected with Early Infantile Epileptic Encephalopathy 18 and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Developmental and epileptic encephalopathy, 18 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.2888A>G (p.K963R) alteration is located in exon 20 (coding exon 20) of the SZT2 gene. This alteration results from a A to G substitution at nucleotide position 2888, causing the lysine (K) at amino acid position 963 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at